Table 3: Clinical characteristics and their association with anemia under unadjusted logistic regression analysis (n = 301).

Background characteristicsFrequency (%)Anemia statusOR (95%CI)Χ2P value

Anemic
frequency (%)
Not anemic
frequency (%)
104(34.6)197(65.4)

CD4 count level (cells/μL) (median CD4 count = 332 ± 195.67)2.170.14
  ≥ 200232(77.1)751571.52[0.87, 2.64]
 <20069(22.9)2940∗∗
WBC count level (cells/μL) (median WBC count = 5490 ± 4013.00)8.330.00∗
 ≥ 4500206(68.4)601462.10[1.27, 3.47]
 <450095(31.6)4451∗∗
Platelet count level (cells/μL) (median platelet count = 287000 ± 97499.53)5.780.01∗
 ≥ 150, 000281(93.4)921893.08[1.22, 7.80]
 <150,00020(6.6)128
BMI (kg/m2)23.450.00∗
 Underweight36(12)241251.67[0.63, 4.44]
 Normal185(61.5)60120.40[0.13, 1.28]
 Overweight62(20.6)12503.33[1.08, 10.25]
 Obese18(6)810∗∗
WHO Clinical HIV/AIDS stage16.720.00∗
 Stage I119(39.5)28913.51[1.90, 6.50]
 Stage II61(20.3)20412.22[1.10, 4.45]
 Stage III44(14.6)16281.89[0.89, 4.44]
 Stage IV77(25.6)4037∗∗
ART regimen1.530.22
 ZDV containing188(62.5)601281.36[0.84, 2.21]
 Not ZDV containing113(37.5)4469∗∗
Anti-Tb treatment history0.610.44
 Yes104(34.6)36650.82[0.50, 1.35]
 No197(65.4)65132∗∗

Note: CD4 = cluster of differentiation 4, WBC = white blood cells, BMI = body mass index, ZDV = zidovudine, μL = microliter.
∗∗ reference; ∗ statistically significant.